Ghidul pentru managementul hipertensiunii arteriale 2007 Grupul ...

Revista Română de CardiologieVol. XXII, Nr. 3, 2007Ghidul pentru managementul hipertensiunii arteriale 2007Ghid al Societăţii Europene de Cardiologieatrial fibrillation: a prospective, randomized study. Circulation 2002;106:331-336. RT.384. Fogari R, Mugellini A, Destro M, Corradi L, Zoppi A, Fogari E,Rinaldi A. Losartan and prevention of atrial fibrillation recurrence inhypertensive patients. J Cardiovasc Pharmacol 2006;47:46-50. RT.385. Disertori M, Latini R, Maggioni AP, Delise P, Di Pasquale G, FranzosiMG, Staszewsky L, Tognoni G. on behalf of the GISSI-AF Investigators;Rationale, design of the GISSI-Atrial Fibrillation Trial: arando mized, prospective, multicentre study on the use of valsartan,an angio tensin II AT 1-receptor blocker, in the prevention of atrialfibri lla tion recurrence. J Cardiovasc Med 2006;7:29-38. RT.386. Wang JG, Staessen JA, Li Y, Van Bortel LM, Nawrot T, Fagard R,Messerli FH, Safar M. Carotid intima-media thickness and antihypertensivereatment: a meta-analysis of randomized controlled trials.Stroke 2006; 37:1933-1940. MA.387. MacMahon S, Sharpe N, Gamble G, Clague A, Mhurchu CN, Clark T,Hart H, Scott J, White H. Randomized, placebo-controlled trial of theangiotensin-converting enzyme inhibitor, ramipril, in patients withcoronary or other occlusive arterial disease. PART-2 CollaborativeResearch Group. Prevention of Atherosclerosis with Ramipril. J AmColl Cardiol 2000; 36:438-443. RT.388. Asselbergs FW, van Roon AR, Hillege HL, de Jong RE, Gans ROB,Smit AJ, van Gilst WH. on behalf of the PREVEND IT Investigators;PREVEND IT Investigators. Effects of fosinopril and pravastatinon carotid intima-media thickness in subjects with increased albuminuria.Stroke 2005; 36:649-653. RT.389. Hedblad B, Wikstrand J, Janzon L, Wedel H, Berglund G. Low-dosemetoprolol CR/XL and fluvastatin slow progression of carotid intimamediathickness: Main results from the Beta-Blocker Cholesterol-LoweringAsymptomatic Plaque Study (BCAPS). Circulation 2001;103:1721-1726. RT.390. Zanchetti A, Crepaldi G, Bond MG, Gallus G, Veglia F, Mancia G,Ventura A, Baggio G, Sampietri L, Rubba P, Sperti G, Magni A. onbehalf of PHYLLIS Investigators. Different effects of antihypertensiveregimens based on fosinopril or hydrochlorothiazide with or withoutlipid lowering by pravastatin on progression of asymptomatic carotidatherosclerosis: principal results of PHYLLIS-a randomized doubleblindtrial. Stroke 2004;35:2807-2812. RT.391. Simon A, Gariepy J, Moyse D, Levenson J. Differential effects of nifedipineand co-amilozide on the progression of early carotid wallchanges. Circulation 2001;103:2949-2954. CT.392. Terpstra WF, May JF, Smit AJ, Graeff PA, Meyboom-de Jong B, CrijnsHJ. Effects of amlodipine and lisinopril on intima-media thicknessin previously untreated, elderly hypertensive patients (the ELVERAtrial). J Hypertens 2004;22:1309-1316. RT.393. Pitt B, Byington RP, Furberg CD, Hunninghake DB, Mancini GBJ,Miller ME, Riley W. Effect of amlodipine on the progression ofatherosclerosis and the occurrence of clinical events. Circulation2000; 102:1503-1510. RT.394. Lonn EM, Yusuf S, Dzavik V, Doris CI, Yi Q, Smith S, Moore-CoxA, Bosch J, Riley WA, Teo KK. Effects of ramipril and vitamin E onatherosclerosis: The Study to Evaluate Carotid Ultrasound changes inpatients treated with Ramipril and vitamin E SECURE). Circulation2001;103:919-925. CT.395. Borhani NO, Mercuri M, Borhani PA, Buckalew VM, Canossa-Terris M, Carr AA, Kappagoda T, Rocco MV, Schnaper HW, SowersJR, Bond MG. Final outcome results of the Multicenter IsradipineDiuretic Atherosclerosis Study (MIDAS). A randomized controlledtrial. JAMA 1996; 276:785-791. RT.396. Ciulla MM, Paliotti R, Ferrero S, Vandoni P, Magrini F, Zanchetti A.Assessment of carotid plaque composition in hypertensive patientsby ultrasonic tissue characterization: a validation study. J Hypertens2002;20:1589-1596.397. Paliotti R, Ciulla MM, Hennig M, Tang R, Bond MG, Mancia G,Magrini F, Zanchetti A. Carotid wall composition in hypertensivepatien ts after 4-year treatment with lacidipine or atenolol: an echoreflectivitystudy. J Hypertens 2005;23:1203-1209. CT.398. Asmar R. Effect of antihypertensive agents on arterial stiffness asevaluated by pulse wave velocity: clinical implications. Am J CardiovascDrugs 2001; 1:387-397. RV.399. Ichihara A, Hayashi M, Koura Y, Tada Y, Hirota N, Saruta T. Longtermeffects of intensive blood-pressure lowering on arterial wall stiffnessin hypertensive patients. Am J Hypertens 2003; 16:959-965. OS.400. Asmar RG, London GM, O’Rourke ME, Safar ME. REASON ProjectCoordinators and Investigators. Improvement in blood pressu re,arterial stiffness and wave reflections with a very-low-dose perin dopril/indapamidecombination in hypertensive patient: a comparisonwith atenolol. Hypertension 2001; 38:922-926. RT.401. RajzerM, KlocekM, Kawecka-Jaszcz K. Effect of amlodipine, quinapril,and losartan on pulse wave velocity and plasma collagen markersin patients with mild-to-moderate arterial hypertension. Am J Hypertens2003; 16:439-444. RT.402. Munakata M, Nagasaki A, Nunokawa T, Sakuma T, Kato H, YoshinagaK, Toyota T. Effects of valsartan and nifedipine coat-core on systemicarterial stiffness in hypertensive patients. Am J Hypertens 2004; 17:1050-1055. RT.403. Dhakam Z, McEniery CM, Yasmin, Cockcroft JR, Brown MJ,Wilkinson IB. Atenolol and eprosartan: differential effects on centralblood pressure and aortic pulse wave velocity. Am J Hypertens 2006;19:214-219. RT.404. Staessen JA, Richart T, Birkenhager WH. Less atherosclerosis andlower blood pressure for a meaningful life perspective with morebrain. Hypertension 2007;49:389-400. RV.405. Dufouil C, Chalmers J, Coskun O, Besancon V, Bousser MG, GuillonP, MacMahon S, Mazoyer B, Neal B, Woodward M, Tzourio-MazoyerN, Tzourio C. PROGRESS MRI Substudy Investigators. Effects ofblood pressure lowering on cerebral white matter hyperintensities inpatients with stroke: the PROGRESS (Perindopril Protection AgainstRecurrent Stroke Study) Magnetic Resonance Imaging Substudy.Circulation 2005; 112:1644-1650. CT.406. Birns J, Morris R, Donaldson N, Kalra L. The effects of blood pressurereduction on cognitive function: a review of effects based on pooleddata from clinical trials. J Hypertens 2006;24:1907-1914. MA.407. Forette F, Seux ML, Staessen JA, Thijs L, Birkenhager WH, BabarskieneMR, Babeanu S, Bossini A, Gil-Extremera B, Girerd X, Laks T, Lilov E,Moisseyev V, Tuomilehto J, Vanhanen H, Webster J, Yodfat Y, FagardR. Prevention of dementia with antihypertensive treatment: newevidence from the Systolic Hypertension in Europe (Syst-Eur) study.Lancet 1998; 352:1347-1351. RT.408. Skoog I, Lithell H, Hansson L, Elmfeldt D, Hofman A, Olofsson B,Trenkwalder P, Zanchetti A. SCOPE Study Group. Effect of baselinecognitive function and antihypertensive treatment on cognitive andcardiovascular outcomes: Study on COgnition and Prognosis in theElderly (SCOPE). Am J Hypertens 2005;18:1052-1059. RT.409. Goldstein G, Materson BJ, Cushman WC, Reda DJ, Freis ED, RamirezEA, Talmers FN, White TJ, Nunn S, Chapman RH. Treatment of hypertensionin the elderly: II. Cognitive and behavioral function. Resultsof a Department of Veterans Affairs Cooperative Study. Hypertension1990;15:361-369. RT.410. McCorvey E Jr, Wright JT Jr, Culbert JP, McKenney JM, Proctor JD,Annett MP. Effect of hydrochlorothiazide, enalapril, and propranololon quality of life and cognitive and motor function in hypertensivepatients. Clin Pharm 1993;12:300-305. RT.411. Leonetti G, Salvetti A. Effects of cilazapril and nitrendipine on bloodpressure, mood, sleep, and cognitive function in elderly hypertensivepatients: an Italian multicenter study. J Cardiovasc Pharmacol 1994;24(Suppl 3):S73-S77. RT.412. Starr JM, Whalley LJ, Deary IJ. The effects of antihypertensive treatmenton cognitive function: results from the HOPE study. J AmGeriatrSoc 1996;44:411-415. CT.413. Fogari R, Mugellini A, Zoppi A, Marasi G, Pasotti C, Poletti L, RinaldiA, Preti P. Effects of valsartan compared with enalapril on blood pressureand cognitive function in elderly patients with essential hypertension.EurJClin Pharmacol 2004;59:863-868. RT.414. Prince MJ, Bird AS, Blizard RA, Mann AH. Is the cognitive functionof older patients affected by antihypertensive treatment? Results from54 months of the Medical Research Council’s trial of hypertension inolder adults. BMJ 1996;312:801-805. CT.